Targeting the HSP90 epichaperome synergized with BCL-2 inhibition to effectively eliminate TP53-mutant AML cells. (Left) Exposure to venetoclax over longer time, MCL-1 expression is elevated. (Right) Addition of PU-H71 decreases MCL-1 expression and induces apoptosis. Figure created with BioRender.com.